154 related articles for article (PubMed ID: 27599670)
21. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
[TBL] [Abstract][Full Text] [Related]
22. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
24. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
26. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.
Subramani R; Lopez-Valdez R; Arumugam A; Nandy S; Boopalan T; Lakshmanaswamy R
PLoS One; 2014; 9(5):e97016. PubMed ID: 24809702
[TBL] [Abstract][Full Text] [Related]
27. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.
Li N; Song MM; Chen XH; Liu LH; Li FS
Biomed Environ Sci; 2012 Aug; 25(4):465-70. PubMed ID: 23026527
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
29. LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells.
Unno J; Satoh K; Hirota M; Kanno A; Hamada S; Ito H; Masamune A; Tsukamoto N; Motoi F; Egawa S; Unno M; Horii A; Shimosegawa T
Int J Oncol; 2009 Oct; 35(4):813-21. PubMed ID: 19724917
[TBL] [Abstract][Full Text] [Related]
30. [Simultaneous inhibition of XIAP and survivin expression on EMT and invasion of human pancreatic cancer cells].
Zai H; Yi X; Li Y; Jiang C; Lu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):883-8. PubMed ID: 23000761
[TBL] [Abstract][Full Text] [Related]
31. INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-β signaling pathway activation.
Zhang H; Huang Y; Wen Q; Li Y; Guo L; Ge N
J Orthop Surg Res; 2023 Nov; 18(1):848. PubMed ID: 37940978
[TBL] [Abstract][Full Text] [Related]
32. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
[TBL] [Abstract][Full Text] [Related]
33. JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells.
Liu Z; Du R; Long J; Dong A; Fan J; Guo K; Xu Y
Tumour Biol; 2012 Oct; 33(5):1527-34. PubMed ID: 22535371
[TBL] [Abstract][Full Text] [Related]
34. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha.
Huang F; Tang J; Zhuang X; Zhuang Y; Cheng W; Chen W; Yao H; Zhang S
PLoS One; 2014; 9(2):e87897. PubMed ID: 24504166
[TBL] [Abstract][Full Text] [Related]
35. Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells.
Fujiwara K; Ohuchida K; Ohtsuka T; Mizumoto K; Shindo K; Ikenaga N; Cui L; Takahata S; Aishima S; Tanaka M
Pancreas; 2013 Nov; 42(8):1283-90. PubMed ID: 24308064
[TBL] [Abstract][Full Text] [Related]
36. Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Lou C; Zhang F; Yang M; Zhao J; Zeng W; Fang X; Zhang Y; Zhang C; Liang W
PLoS One; 2012; 7(12):e50956. PubMed ID: 23300530
[TBL] [Abstract][Full Text] [Related]
37. Implication of EMT induced by TGF-beta1 in pancreatic cancer.
Yin T; Wang C; Liu T; Zhao G; Zhou F
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):700-2. PubMed ID: 17357493
[TBL] [Abstract][Full Text] [Related]
38. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.
Arumugam T; Ramachandran V; Fournier KF; Wang H; Marquis L; Abbruzzese JL; Gallick GE; Logsdon CD; McConkey DJ; Choi W
Cancer Res; 2009 Jul; 69(14):5820-8. PubMed ID: 19584296
[TBL] [Abstract][Full Text] [Related]
39. Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L.
Sugiura T; Noguchi Y; Sakurai K; Hattori C
Cancer Biol Ther; 2008 Feb; 7(2):285-92. PubMed ID: 18059182
[TBL] [Abstract][Full Text] [Related]
40. The Regulatory Role of
Chen F; Zheng Y; Zhou H; Li C
Cancer Biother Radiopharm; 2024 Apr; 39(3):211-222. PubMed ID: 35802495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]